论文部分内容阅读
目的:探究米索前列醇联合缩宫素应用在无痛人流中的临床效果。方法:选取近期来我院就诊的36例患者随机分为观察组与对照组,对观察组患者给予药物米索前列醇、缩宫素,对照组患者给予药物丙泊酚、芬太尼,对比分析患者用药后术中、术后各方面情况。结果:使用药物米索前列醇、缩宫素的小组术中手术时间仅用了5min左右,出血量为14ml左右,术后出血时间为1周左右,且无人流不全、子宫穿孔现象,且再次清宫率低。前后两小组对比差异显著(P<0.05)。结论:将药物米索前列醇、缩宫素等应用到无痛人流中,可提升宫颈扩张度,减少宫颈损伤,减轻患者术中痛苦,增加患者宫缩频率,可缩短手术操作时间,提高手术完成质量,可作为无痛人流术中的首选药物。
Objective: To investigate the clinical effect of misoprostol combined with oxytocin in painless abortion. Methods: Thirty-six patients who were treated in our hospital recently were randomly divided into observation group and control group. Patients in observation group were treated with misoprostol and oxytocin, and patients in control group were given propofol and fentanyl. Analysis of patients after surgery, all aspects of postoperative. Results: The group treated with the drug misoprostol and oxytocin only took about 5 minutes and the bleeding volume was about 14ml. The postoperative bleeding time was about 1 week, and there was no abortion and uterine perforation, and again Qing rate is low. Before and after the two groups significant difference (P <0.05). Conclusion: The application of misoprostol and oxytocin to painless abortion can improve cervical dilatation, reduce cervical injury, reduce intraoperative pain and increase the frequency of uterine contractions in patients, which can shorten the operation time and improve the operation Complete quality, can be used as painless abortion in the drug of choice.